Stock Analysis

Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) top holders are insiders and they are likely disappointed by the recent 12% drop

Published
BOVESPA:OFSA3

Key Insights

  • Ouro Fino Saúde Animal Participações' significant insider ownership suggests inherent interests in company's expansion
  • 58% of the business is held by the top 2 shareholders
  • Past performance of a company along with ownership data serve to give a strong idea about prospects for a business

If you want to know who really controls Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 56% to be precise, is individual insiders. Put another way, the group faces the maximum upside potential (or downside risk).

As a result, insiders as a group endured the highest losses after market cap fell by R$137m.

Let's take a closer look to see what the different types of shareholders can tell us about Ouro Fino Saúde Animal Participações.

View our latest analysis for Ouro Fino Saúde Animal Participações

BOVESPA:OFSA3 Ownership Breakdown October 30th 2023

What Does The Institutional Ownership Tell Us About Ouro Fino Saúde Animal Participações?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

Institutions have a very small stake in Ouro Fino Saúde Animal Participações. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment. So if the company itself can improve over time, we may well see more institutional buyers in the future. We sometimes see a rising share price when a few big institutions want to buy a certain stock at the same time. The history of earnings and revenue, which you can see below, could be helpful in considering if more institutional investors will want the stock. Of course, there are plenty of other factors to consider, too.

BOVESPA:OFSA3 Earnings and Revenue Growth October 30th 2023

We note that hedge funds don't have a meaningful investment in Ouro Fino Saúde Animal Participações. Mitsui & Co., Ltd. is currently the company's largest shareholder with 30% of shares outstanding. In comparison, the second and third largest shareholders hold about 29% and 28% of the stock. Norival Bonamichi, who is the third-largest shareholder, also happens to hold the title of Vice Chairman.

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is some analyst coverage of the stock, but it could still become more well known, with time.

Insider Ownership Of Ouro Fino Saúde Animal Participações

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

It seems that insiders own more than half the Ouro Fino Saúde Animal Participações S.A. stock. This gives them a lot of power. So they have a R$573m stake in this R$1.0b business. Most would be pleased to see the board is investing alongside them. You may wish todiscover (for free) if they have been buying or selling.

General Public Ownership

The general public-- including retail investors -- own 11% stake in the company, and hence can't easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Public Company Ownership

It appears to us that public companies own 30% of Ouro Fino Saúde Animal Participações. It's hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it's worth watching this space for changes in ownership.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Ouro Fino Saúde Animal Participações better, we need to consider many other factors. Take risks for example - Ouro Fino Saúde Animal Participações has 1 warning sign we think you should be aware of.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.